Platelet aggregation unchanged by lipoprotein-associated phospholipase A₂ inhibition: results from an in vitro study and two randomized phase I trials.
We explored the theorized upregulation of platelet-activating factor (PAF)- mediated biologic responses following lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibition using human platelet aggregation studies in an in vitro experiment and in 2 clinical trials.Full platelet aggregation concent...
Main Authors: | Bonnie C Shaddinger, Yanmei Xu, James H Roger, Colin H Macphee, Malcolm Handel, Charlotte A Baidoo, Mindy Magee, John J Lepore, Dennis L Sprecher |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3903475?pdf=render |
Similar Items
-
THE UNCHANGEABLE ESSENCE BUT CHANGEABLE AND UNCHANGEABLE ATTRIBUTES
by: Ahmad Beheshti
Published: (2012-07-01) -
VAP rates unchanged
by: Robbins RA
Published: (2016-12-01) -
Effect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trial.
by: Joel L Johnson, et al.
Published: (2014-01-01) -
Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis[S]
by: Kasey C. Vickers, et al.
Published: (2009-09-01) -
Changing and unchanging of the graph parameters
by: LOU,ZHI-HONG, et al.
Published: (1991)